Synthesis of New 1-Substituted-3-(3-(2-Chlorophenyl)-4-Oxo-3,4-Dihydrobenzopyrimidin-2-Ylamino)Isothioureas as Anti-HIV and Antibacterial Agents

In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)iso...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical chemistry journal Vol. 55; no. 1; pp. 54 - 59
Main Authors Narendhar, B., Chitra, K., Alagarsamy, V.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)isothioureas 7A – 7J were obtained via reactions of 2-hydrazino-3-(2-chlorophenyl)quinazolin-4(3 H) -one ( 5 ) with different alkyl/aryl isothiocyanates followed by methylation with dimethyl sulphate. All synthesized compounds were screened for their antitubercular, anti-HIV, and antibacterial activity against selected Gram-positive and Gram-negative bacteria using agar diffusion method. Amongst, compounds 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chloropheny)isothiourea (7I) and 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chlorophenyl)isothiourea (7F) showed the most potent activity against P. vulgaris and S. aureus with a MIC of 3 μg/mL . Compound 7I exhibited antitubercular activity at a minimum MIC of 3.125 μg/mL and anti-HIV activity at EC 50 of 2.91 μg/mL against HIV1 and HIV2, thus offering probable lead for further development and optimization of new antitubercular and anti-HIV drugs. Results obtained in this study confirm that the synthesized and biologically evaluated benzopyrimidines possess promising antimicrobial, antitubercular, and anti-HIV properties and provide new scaffolds for antimicrobial activity.
AbstractList In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)isothioureas 7A – 7J were obtained via reactions of 2-hydrazino-3-(2-chlorophenyl)quinazolin-4(3 H) -one ( 5 ) with different alkyl/aryl isothiocyanates followed by methylation with dimethyl sulphate. All synthesized compounds were screened for their antitubercular, anti-HIV, and antibacterial activity against selected Gram-positive and Gram-negative bacteria using agar diffusion method. Amongst, compounds 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chloropheny)isothiourea (7I) and 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chlorophenyl)isothiourea (7F) showed the most potent activity against P. vulgaris and S. aureus with a MIC of 3 μg/mL . Compound 7I exhibited antitubercular activity at a minimum MIC of 3.125 μg/mL and anti-HIV activity at EC 50 of 2.91 μg/mL against HIV1 and HIV2, thus offering probable lead for further development and optimization of new antitubercular and anti-HIV drugs. Results obtained in this study confirm that the synthesized and biologically evaluated benzopyrimidines possess promising antimicrobial, antitubercular, and anti-HIV properties and provide new scaffolds for antimicrobial activity.
Author Chitra, K.
Alagarsamy, V.
Narendhar, B.
Author_xml – sequence: 1
  givenname: B.
  surname: Narendhar
  fullname: Narendhar, B.
  organization: Medicinal Chemistry Research Laboratory, MNR College of Pharmacy
– sequence: 2
  givenname: K.
  surname: Chitra
  fullname: Chitra, K.
  organization: Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)
– sequence: 3
  givenname: V.
  surname: Alagarsamy
  fullname: Alagarsamy, V.
  email: drvalagarsamy@gmail.com
  organization: Medicinal Chemistry Research Laboratory, MNR College of Pharmacy
BookMark eNp9kNtKAzEQhoMoWA8v4NVeWnA0p900l6WeCqIXHtCrJbub7aZsk5Kk6PoUPrLRei38wzAw__DPd4B2rbMaoROCzwnG4iIQgiUHTEkqJgiIHTQiuWAgMSO7aISxJEBy_LqPDkJYYpxsjI7Q1-NgY6eDCZlrs3v9nhF43FQhmriJugEGp0kUZl3vvFt32g79GDg8fDhgZxwuTTc03lXafrr14M3KNMYChbderYx143lwsTNu47UKWdLURgO385dM2eZ3qFQdtTeqz6YLbWM4Qnut6oM-_uuH6Pn66ml2C3cPN_PZ9A5qKkmEvOWVmChaqFbRXBEx0RWTXIuCs6blE9w2RHKuGymKRuKcF6KqqWJcy4LUomKHiG7v1t6F4HVbrlN65YeS4PKHabllWiam5S_TUiQT25pCWrYL7ctles2mnP-5vgG30Hva
CitedBy_id crossref_primary_10_31857_S0514749223010044
crossref_primary_10_2174_1573406418666220620124034
crossref_primary_10_1134_S1070428023010037
crossref_primary_10_1134_S1070428023070035
crossref_primary_10_31857_S0514749223070030
crossref_primary_10_1002_cbdv_202300702
Cites_doi 10.1021/ar7000843
10.1016/j.ejmech.2007.07.001
10.1016/j.bmcl.2008.12.088
10.4067/S0717-97072016000200002
10.1134/S106816201603002X
10.3402/gha.v8.27048
10.1080/13543776.2018.1432596
10.1016/j.bmc.2007.05.063
10.1016/j.ejmech.2018.03.076
10.1021/jm060339h
10.1111/j.1747-0285.2009.00794.x
10.1016/0223-5234(87)90277-7
10.1016/S1473-3099(09)70043-X
10.1016/j.bmc.2008.08.050
10.1016/j.ejmech.2010.01.028
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2021
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2021
DBID AAYXX
CITATION
DOI 10.1007/s11094-021-02371-7
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1573-9031
EndPage 59
ExternalDocumentID 10_1007_s11094_021_02371_7
GroupedDBID ---
-53
-58
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
1N0
1SB
2.D
28-
29O
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
4.4
406
408
409
40D
40E
41~
53G
5QI
5VS
642
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACUDM
ACVWB
ACWMK
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFGCZ
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
ESBYG
ESX
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IAO
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
LAK
LLZTM
M4Y
MA-
MK0
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P9N
PF0
PT4
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SCLPG
SCM
SDE
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
W4F
WJK
WK8
XU3
YLTOR
Z7U
Z7V
Z7W
Z87
Z8O
Z8P
Z8Q
Z91
ZGI
ZMTXR
ZOVNA
~8M
~A9
~EX
~KM
AACDK
AAEOY
AAJBT
AASML
AAYXX
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
CITATION
H13
ID FETCH-LOGICAL-c291t-5f4b78a26afa25a178eb394e7643df480fd1944ed976d905467bc2a34e961c7b3
IEDL.DBID U2A
ISSN 0091-150X
IngestDate Thu Sep 12 16:36:59 EDT 2024
Sat Dec 16 12:09:56 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords substituted thiosemicarbazide
quinazolinone
antibacterial activity, antitubercular activity, anti-HIV activity
condensed pyrimidine
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c291t-5f4b78a26afa25a178eb394e7643df480fd1944ed976d905467bc2a34e961c7b3
PageCount 6
ParticipantIDs crossref_primary_10_1007_s11094_021_02371_7
springer_journals_10_1007_s11094_021_02371_7
PublicationCentury 2000
PublicationDate 2021-04-01
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
PublicationTitle Pharmaceutical chemistry journal
PublicationTitleAbbrev Pharm Chem J
PublicationYear 2021
Publisher Springer US
Publisher_xml – name: Springer US
References AlagarsamyVSolomonVRSheoreyRVChem. Biol. Drug. Des.2009734714791:CAS:528:DC%2BD1MXktVWhsrc%3D10.1111/j.1747-0285.2009.00794.x
KaraliNGürsoyAKandemirliFBioorg. Med. Chem.200715588859041:CAS:528:DC%2BD2sXnslWjtr8%3D10.1016/j.bmc.2007.05.063
Turan-ZitouniGOzdemirAKaplancikliZAEur. J. Med. Chem.2008439819851:CAS:528:DC%2BD1cXlslKmu70%3D10.1016/j.ejmech.2007.07.001
MeunierBAcc. Chem. Res.20084169771:CAS:528:DC%2BD2sXotlOjtr8%3D10.1021/ar7000843
HameedAAl-RashidaMUroosMExpert Opin. Ther. Pat.2018282812971:CAS:528:DC%2BC1cXisVektbs%3D10.1080/13543776.2018.1432596
AlagarsamyVAnjanaGVSulthanaMTRuss. J Bioorg. Chem.2016423323391:CAS:528:DC%2BC28XovV2isrc%3D10.1134/S106816201603002X
GüzelOKaraliNSalmanABioorg. Med. Chem.2008168976898710.1016/j.bmc.2008.08.050
FarghalyAMOmarAMMEKhalilMAEur. J. Med. Chem.1987223693711:CAS:528:DyaL1cXhtFagur0%3D10.1016/0223-5234(87)90277-7
WHO: Global Tuberculosis Report 2018, World Health Organization, Geneva, Switzerland (2018).
F. R. Pavan, P. I. Da S Maia, S. R. Leite, et. al., Eur. J. Med. Chem.,45, 1898 – 1905 (2010).
PandeyaSNSmithaSJyotiMActa. Pharm.20055527461:CAS:528:DC%2BD2MXksVagsrs%3D15907222
V. Alagarsamy, K. Chitra, G. Saravanan, et. al., Eur. J. Med. Chem., 151, 628 – 685 (2018).
WHO: Tuberculosis, Available online: https://www.who.int / tb/en/ (accessed on 17 March 2019).
SriramDYogeeswariPThirumuruganRJ. Med. Chem.200649344834501:CAS:528:DC%2BD28XkslKhtL0%3D10.1021/jm060339h
B. Milczarska, H. Foks, J. Sokołowska, et al., Acta Pol. Pharm.,56, 121 – 126 (1999).
E. Saripinar, Y. Güzel, S. Patat, et. al., Arzneimittelforschung, 46, 824 – 828 (1996).
ReidMJShahNSLancet Infect. Dis.2009917318410.1016/S1473-3099(09)70043-X
AlagarsamyVAppaniRSulthanaMTJ Chil. Chem. Soc.201661285628601:CAS:528:DC%2BC28Xhs1Oqur7F10.4067/S0717-97072016000200002
BalchaTTSkogmarSSturegårdEGlob. Health Action20158270482704910.3402/gha.v8.27048
SriramDYogeeswariPDhaklaPBioorg. Med. Chem. Lett.200919115211541:CAS:528:DC%2BD1MXit1WrtLc%3D10.1016/j.bmcl.2008.12.088
V Alagarsamy (2371_CR17) 2009; 73
D Sriram (2371_CR11) 2009; 19
SN Pandeya (2371_CR15) 2005; 55
N Karali (2371_CR9) 2007; 15
A Hameed (2371_CR6) 2018; 28
G Turan-Zitouni (2371_CR14) 2008; 43
O Güzel (2371_CR8) 2008; 16
D Sriram (2371_CR10) 2006; 49
TT Balcha (2371_CR2) 2015; 8
2371_CR1
2371_CR4
B Meunier (2371_CR16) 2008; 41
2371_CR5
V Alagarsamy (2371_CR19) 2016; 42
2371_CR7
AM Farghaly (2371_CR20) 1987; 22
MJ Reid (2371_CR3) 2009; 9
2371_CR12
2371_CR13
V Alagarsamy (2371_CR18) 2016; 61
References_xml – volume: 41
  start-page: 69
  year: 2008
  ident: 2371_CR16
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar7000843
  contributor:
    fullname: B Meunier
– volume: 43
  start-page: 981
  year: 2008
  ident: 2371_CR14
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2007.07.001
  contributor:
    fullname: G Turan-Zitouni
– volume: 19
  start-page: 1152
  year: 2009
  ident: 2371_CR11
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2008.12.088
  contributor:
    fullname: D Sriram
– ident: 2371_CR4
– volume: 55
  start-page: 27
  year: 2005
  ident: 2371_CR15
  publication-title: Acta. Pharm.
  contributor:
    fullname: SN Pandeya
– volume: 61
  start-page: 2856
  year: 2016
  ident: 2371_CR18
  publication-title: J Chil. Chem. Soc.
  doi: 10.4067/S0717-97072016000200002
  contributor:
    fullname: V Alagarsamy
– volume: 42
  start-page: 332
  year: 2016
  ident: 2371_CR19
  publication-title: Russ. J Bioorg. Chem.
  doi: 10.1134/S106816201603002X
  contributor:
    fullname: V Alagarsamy
– ident: 2371_CR1
– volume: 8
  start-page: 27048
  year: 2015
  ident: 2371_CR2
  publication-title: Glob. Health Action
  doi: 10.3402/gha.v8.27048
  contributor:
    fullname: TT Balcha
– volume: 28
  start-page: 281
  year: 2018
  ident: 2371_CR6
  publication-title: Expert Opin. Ther. Pat.
  doi: 10.1080/13543776.2018.1432596
  contributor:
    fullname: A Hameed
– ident: 2371_CR12
– ident: 2371_CR13
– volume: 15
  start-page: 5888
  year: 2007
  ident: 2371_CR9
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2007.05.063
  contributor:
    fullname: N Karali
– ident: 2371_CR5
  doi: 10.1016/j.ejmech.2018.03.076
– volume: 49
  start-page: 3448
  year: 2006
  ident: 2371_CR10
  publication-title: J. Med. Chem.
  doi: 10.1021/jm060339h
  contributor:
    fullname: D Sriram
– volume: 73
  start-page: 471
  year: 2009
  ident: 2371_CR17
  publication-title: Chem. Biol. Drug. Des.
  doi: 10.1111/j.1747-0285.2009.00794.x
  contributor:
    fullname: V Alagarsamy
– volume: 22
  start-page: 369
  year: 1987
  ident: 2371_CR20
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/0223-5234(87)90277-7
  contributor:
    fullname: AM Farghaly
– volume: 9
  start-page: 173
  year: 2009
  ident: 2371_CR3
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(09)70043-X
  contributor:
    fullname: MJ Reid
– volume: 16
  start-page: 8976
  year: 2008
  ident: 2371_CR8
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2008.08.050
  contributor:
    fullname: O Güzel
– ident: 2371_CR7
  doi: 10.1016/j.ejmech.2010.01.028
SSID ssj0010032
Score 2.2781537
Snippet In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2...
SourceID crossref
springer
SourceType Aggregation Database
Publisher
StartPage 54
SubjectTerms Medicine
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
Title Synthesis of New 1-Substituted-3-(3-(2-Chlorophenyl)-4-Oxo-3,4-Dihydrobenzopyrimidin-2-Ylamino)Isothioureas as Anti-HIV and Antibacterial Agents
URI https://link.springer.com/article/10.1007/s11094-021-02371-7
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Na9wwEBVtAm0vIdm25KtBhxIaugMrWbbs47JNumlpG2i2bE5GXknEUOQQbyDOr8hPzkj2xgRKIaCLQQjMm9G8YWaeCPmoLfOtFgIw1I1AmChDl4olmEzoRBimmQ5qnz-T6Ux8m8fzfo47NLuvKpLhou5n3djIq9hyzH55JBnIl2Q99nJoaMQzPn4sHaCZthLhGQNkO_NuUubfZzyNRk9LoSHCnGySjY4a0nGL5RZ5YdyAvJ6sXmQbkFc_ukL4gByetZLTzZCe9xNU9ZAe0rNejLp5S-5_Nw45Xl3WtLIUrzTKwF8WbYeAhgg-4eIwucTE3WsMuObvEQj4dVtBNBTwpbxstB8ZcnfVVePfAMNgBxwu0JJKVx2d1gh1WYXedopr7JYlTE__UOV0-ChaOWj_Y36Kq35HZifH55MpdK8wwIJnbAmxFYVMFU-UVTxWTKaYf2fCSOQy2op0ZDXLhDAa0dYZMsBEFguuImGyhC1kEb0na65yZptQzFWNHUllF0hiLHq-zy_jJDWpV4lRaod8XqGRX7ViG3kvq-yxyxG7PGCXyx0yXAGWd45X_2f77vO275E3PBiKb9LZJ2vL6xvzAfnHsjgg6-OvF9-PD4LdPQBhstDn
link.rule.ids 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3batwwEB3aDTR96WXb0PSqhxIauhNWsmzZj8s26W5zaaC7ZfNkbEsmpsEOsQN1vqKf3JEvXVJKIeAXgzAyczRzhpk5AnivU25bLSRSqBujNE5AR8pVaAKpPWm45rpR-zzxZkv5ZeWuuqGwsu9270uSjadeD7vxsZWxFZT-CkdxVPdhQwruiQFsTD6fHe7_qR4QUluV8IAjEZ5VNyzz76_cDki3q6FNkDl4DMt-e21vyY-96yreS27-Um686_6fwKOOdbJJC5OncM_kQ9ic9pe9DeHBcVdjH8LOaatmXY_YYj2cVY7YDjtd61zXz-DXtzon-lhmJStSRt6ScbR-qG0-0OjgB3oETs8viisrX5DXF7so8evPAp2RxE_Zea3tNFJ-U1zW9noxiqMo8IxAmuXF7rwkFGVF0zbP6JnkVYaz-XcW5bp5iVulaftjdkCsfA7Lg_3FdIbdBQ-YiIBX6KYyVn4kvCiNhBtx5VNqH0ijiCbpVPrjVPNASqMJSDogcumpOBGRI03g8UTFzhYM8iI3L4BRGmzSsYrShPhRSk7Fpq6u5xvfCtBE0TZ87K0cXrY6HuFasdlaJiTLhI1lQrUNo96GYXemy_8sf3m35e9gc7Y4PgqP5ieHr-ChaCBhe4Few6C6ujZviOZU8dsO1b8BUALvnA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFBZbCt1edslW1l31MMrKctrIViz7MaTNknXrAmtH-mRkS6JmRQ61C3N_xX7yjnxZ1jEGY6AXgxAW55POOZzzfSLktTLMtVpwQFc3BK79CI_USICOuAq4ZoqpWu3zOJid8vfL0fIXFn_d7d6VJBtOg1NpsuX-Spn9NfGNDZ2krYepsOcLBuI22eBOGalHNsbvzo4Of1YSELWNYnjEAIOfZUuc-fMqN53Tzcpo7XCm94nsfrXpM_m6d1Ume-n1byqO_7OXB-ReG43ScQOfh-SWtn1yZ9I9Atcnmx_b2nuf7CwaletqQE_WpK1iQHfoYq1_XT0i3z9XFsPKIitobijeopSBu5-apgQFPrzB4cHk_CK_dLIGtrrYBQ6fvuXgDzgcZOeVciwle52vKvfsGPpX8OAMwZvZfHdeILqyvG6npzjGtsxgNv9CpVX1R9IoULuNOeJY8ZicTg9PJjNoH36A1ItYCSPDExFKL5BGeiPJRIgpf8S1wPBJGR4OjWIR51ohwFSEQWcgktSTPtdRwFKR-FukZ3OrnxCK6bE2QyFNinGTwcvGpbSjINShE6aRcpu87Swerxp9j3it5OwsE6Nl4toysdgmg86ecXvWi79Mf_pv01-RzcXBNP4wPz56Ru56NSJci9Bz0isvr_QLjH7K5GUL8B9fEviA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+of+New+1-Substituted-3-%283-%282-Chlorophenyl%29-4-Oxo-3%2C4-Dihydrobenzopyrimidin-2-Ylamino%29Isothioureas+as+Anti-HIV+and+Antibacterial+Agents&rft.jtitle=Pharmaceutical+chemistry+journal&rft.au=Narendhar%2C+B.&rft.au=Chitra%2C+K.&rft.au=Alagarsamy%2C+V.&rft.date=2021-04-01&rft.issn=0091-150X&rft.eissn=1573-9031&rft.volume=55&rft.issue=1&rft.spage=54&rft.epage=59&rft_id=info:doi/10.1007%2Fs11094-021-02371-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11094_021_02371_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-150X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-150X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-150X&client=summon